PUBLISHER: TechNavio | PRODUCT CODE: 1384516
PUBLISHER: TechNavio | PRODUCT CODE: 1384516
The marine pharmaceuticals market is forecasted to grow by USD 1956.93 mn during 2023-2028, accelerating at a CAGR of 8.63% during the forecast period. The report on the marine pharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising consumer demand for natural products, the growing prevalence of chronic diseases, and the presence of rich marine biodiversity.
Market Scope | |
---|---|
Base Year | 2023 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 7.45% |
CAGR | 8.63% |
Incremental Value | $1956.93mn |
Technavio's marine pharmaceuticals market is segmented as below:
By Product
By Type
By Geographical Landscape
This study identifies the rise of antibiotics from marine microbes as one of the prime reasons driving the marine pharmaceuticals market growth during the next few years. Also, research for anti-inflammatory compounds from marine sources and the emergence of digitalization and data analytics will lead to sizable demand in the market.
The report on the marine pharmaceuticals market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading marine pharmaceuticals market vendors that include Abbott Laboratories, BASF SE, BeyondSpring Inc., BioMarin Pharmaceutical Inc., Bristol Myers Squibb Co., Croda International Plc, DEKRA SE, EID Parry India Ltd., Eisai Co. Ltd., GFR Pharma, GlaxoSmithKline Plc, Jazz Pharmaceuticals Plc, Koninklijke DSM NV, MARINE LIFESCIENCES, Merck KGaA, Pfizer Inc., PharmaMar SA, Roquette Freres SA, TerSera Therapeutics LLC, and ZELNOVA ZELTIA S.A.. Also, the marine pharmaceuticals market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: